GlobeNewswire Inc.··NaImmutrin Bolsters Leadership With Cardiovascular Expert as CMO, Launches US Operations
Biotech firm Immutrin appoints Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary to advance amyloidosis antibody therapy toward clinical trials.
MRKEWTXclinical developmentcardiovascular